UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.6% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
8801
REX IncomeMax Option Strategy ETF
ULTI
$15.9M
| $5.65K | ﹤0.01% |
+487
| New | +$6.54K |
2026 Q2
0 quarters
|
|
8802
NMP Acquisition Corp Units
NMPAU
| $5.64K | ﹤0.01% |
553
| – | – |
2025 Q3
3 quarters
|
|
8803
LQR House Inc
YHC
$2.28M
| $5.63K | ﹤0.01% |
712
+311
| +78% | +$27.3K |
2024 Q3
7 quarters
|
|
8804
DELISTED
Origin Materials
ORGN
| $5.62K | ﹤0.01% |
5,677
-6,016
| -51% | -$9.8K |
2020 Q4
22 quarters
|
|
8805
Royalty Management
RMCO
$33.2M
| $5.6K | ﹤0.01% |
2,138
-1,598
| -43% | -$4.24K |
2024 Q4
6 quarters
|
|
8806
Star Equity Holdings
STRR
$33.6M
| $5.59K | ﹤0.01% |
524
+523
| +52,300% | +$5.42K |
2020 Q4
22 quarters
|
|
8807
YieldMax HIMS Option Income Strategy ETF
HIYY
$8.45M
| $5.58K | ﹤0.01% |
335
+175
| +109% | +$2.67K |
2026 Q1
1 quarter
|
|
8808
Genenta Science
SAEN
$32.8M
| $5.57K | ﹤0.01% |
3,027
-80
| -3% | -$86 |
2025 Q4
2 quarters
|
|
8809
CitroTech Inc
CITR
$58.6M
| $5.56K | ﹤0.01% |
1,008
+84
| +9% | +$594 |
2026 Q1
1 quarter
|
|
8810
Boxlight
BOXL
$1.64M
| $5.55K | ﹤0.01% |
1,179
+875
| +288% | +$4.87K |
2023 Q3
11 quarters
|
|
8811
PhenixFIN
PFX
$78.8M
| $5.53K | ﹤0.01% |
130
-358
| -73% | -$15K |
2014 Q4
46 quarters
|
|
8812
Shengfeng Development Ltd
SFWL
| $5.53K | ﹤0.01% |
436
+395
| +963% | +$5.4K |
2025 Q4
2 quarters
|
|
8813
Phio Pharmaceuticals
PHIO
$9.8M
| $5.52K | ﹤0.01% |
5,387
-21,600
| -80% | -$24.6K |
2025 Q3
3 quarters
|
|
8814
John Hancock Fundamental All Cap Core ETF
JHAC
$3.83M
| $5.5K | ﹤0.01% |
373
+100
| +37% | +$1.48K |
2024 Q3
7 quarters
|
|
8815
Local Bounti
LOCL
$18.8M
| $5.48K | ﹤0.01% |
+4,249
| New | +$7.13K |
2026 Q2
0 quarters
|
|
8816
SVRN, Inc. Common Stock
SVRN
$29.4M
| $5.46K | ﹤0.01% |
698
-1,337
| -66% | -$12.5K |
2025 Q3
3 quarters
|
|
8817
2x Chainlink ETF
CHNU
$1.08M
| $5.46K | ﹤0.01% |
+452
| New | +$9K |
2026 Q2
0 quarters
|
|
8818
Columbia Corporate Bond ETF
CCRP
$51.5M
| $5.46K | ﹤0.01% |
276
| – | – |
2025 Q4
2 quarters
|
|
8819
Calamos Bitcoin Structured Alt Protection ETF - January
CBOJ
$16.8M
| $5.41K | ﹤0.01% |
+230
| New | +$5.41K |
2026 Q2
0 quarters
|
|
8820
iOThree Ltd
IOTR
| $5.41K | ﹤0.01% |
+2,363
| New | +$6.43K |
2026 Q2
0 quarters
|
|
8821
Zhengye Biotechnology Holding
ZYBT
$70.6M
| $5.41K | ﹤0.01% |
7,992
-44
| -0.5% | -$39 |
2025 Q1
5 quarters
|
|
8822
Actuate Therapeutics
ACTU
$7.53M
| $5.41K | ﹤0.01% |
3,534
+1,583
| +81% | +$3.67K |
2024 Q4
6 quarters
|
|
8823
Aware
AWRE
$20.6M
| $5.4K | ﹤0.01% |
4,000
-309
| -7% | -$412 |
2017 Q3
35 quarters
|
|
8824
KraneShares 100% KWEB Defined Outcome January 2026 ETF
KPRO
$3.29M
| $5.4K | ﹤0.01% |
+203
| New | +$5.5K |
2026 Q2
0 quarters
|
|
8825
EQV Ventures Acquisition Corp II Units
EVAC.U
| $5.39K | ﹤0.01% |
524
| – | – |
2025 Q3
3 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,282 new, 4,216 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,282 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.